Wykoff, Charles C <br/><br/>
Neovascular age-related macular degeneration management in the third year: final results from the TREX-AMD randomised trial.  [electronic resource] 

 -  The British journal of ophthalmology  04 2018 
 - 460-464 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2079 
<br/><br/><label>Standard No.: </label>10.1136/bjophthalmol-2017-310822  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Choroidal Neovascularization--drug therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Ranibizumab--therapeutic use<br/>Visual Acuity